(Q54290679)

27 May 2018

title

Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression. (English)

1 reference

27 May 2018

1 reference

1 reference

Yan-Qiu Wang

1

1 reference

27 May 2018

Qin Yan

2

1 reference

27 May 2018

Jia-Rong Zhang

3

1 reference

27 May 2018

Shuang-Di Li

4

1 reference

27 May 2018

Yi-Xia Yang

5

1 reference

27 May 2018

Xiao-Ping Wan

6

1 reference

27 May 2018

publication date

25 September 2012

1 reference

27 May 2018

Journal of Obstetrics and Gynaecology Research

published in

1 reference

27 May 2018

volume

39

1 reference

27 May 2018

issue

2

1 reference

27 May 2018

page(s)

549-554

1 reference

27 May 2018

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

The power and the promise of DNA methylation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

BRCA1 and implications for response to chemotherapy in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

BRCA1 and BRCA2: 1994 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Improved survival in women with BRCA-associated ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Aberrant methylation of breast and ovarian cancer susceptibility gene 1 in chemosensitive human ovarian cancer cells does not involve the phosphatidylinositol 3'-kinase-Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Isolation and initial characterization of the BRCA2 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Ku80 gene expression is Sp1-dependent and sensitive to CpG methylation within a novel cis element

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

BRCA1 interacts with components of the histone deacetylase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

Tumor Cell-SpecificBRCA1andRASSF1AHypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2012.01979.X

10.1111/J.1447-0756.2012.01979.X

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018